BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38141579)

  • 21. CT predictors of outcomes in patients with connective tissue disease and progressive lung fibrosis.
    Shou AY; Salvatore MM
    Clin Imaging; 2023 Feb; 94():42-49. PubMed ID: 36493681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
    Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
    Behr J; Prasse A; Kreuter M; Johow J; Rabe KF; Bonella F; Bonnet R; Grohe C; Held M; Wilkens H; Hammerl P; Koschel D; Blaas S; Wirtz H; Ficker JH; Neumeister W; Schönfeld N; Claussen M; Kneidinger N; Frankenberger M; Hummler S; Kahn N; Tello S; Freise J; Welte T; Neuser P; Günther A;
    Lancet Respir Med; 2021 May; 9(5):476-486. PubMed ID: 33798455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
    Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
    PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
    Chen N; Diao CY; Gao J; Zhao DB
    Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases.
    Mononen M; Saari E; Hasala H; Kettunen HP; Suoranta S; Nurmi H; Kärkkäinen M; Selander T; Randell J; Laurikka J; Uibu T; Koskela H; Kaarteenaho R; Purokivi M
    BMC Pulm Med; 2022 Aug; 22(1):313. PubMed ID: 35965320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors.
    Forestier A; Le Gouellec N; Béhal H; Kramer G; Perez T; Sobanski V; Dubois SM; Lambert M; Hatron PY; Hachulla E; Duhamel A; Matran R; Launay D; Rémy-Jardin M
    Semin Arthritis Rheum; 2020 Dec; 50(6):1406-1413. PubMed ID: 32245698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.
    Wu W; Jordan S; Becker MO; Dobrota R; Maurer B; Fretheim H; Ye S; Siegert E; Allanore Y; Hoffmann-Vold AM; Distler O
    Ann Rheum Dis; 2018 Sep; 77(9):1326-1332. PubMed ID: 29875097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.
    Kawano-Dourado L; Doyle TJ; Bonfiglioli K; Sawamura MVY; Nakagawa RH; Arimura FE; Lee HJ; Rangel DAS; Bueno C; Carvalho CRR; Sabbag ML; Molina C; Rosas IO; Kairalla RA
    Chest; 2020 Oct; 158(4):1546-1554. PubMed ID: 32428513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases.
    Chiu YH; Spierings J; de Jong PA; Hoesein FM; Grutters JC; van Laar JM; Voortman M
    Respir Med; 2021 Oct; 187():106579. PubMed ID: 34438351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
    Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
    Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?
    Tang H; Ren Y; She Y; Dai C; Wang T; Su H; Sun W; Jiang G; Chen C
    Ther Adv Respir Dis; 2020; 14():1753466620971137. PubMed ID: 33167797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pictorial Review of Fibrotic Interstitial Lung Disease on High-Resolution CT Scan and Updated Classification.
    Brixey AG; Oh AS; Alsamarraie A; Chung JH
    Chest; 2024 Apr; 165(4):908-923. PubMed ID: 38056824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of mediastinal lymph node enlargement in chronic interstitial lung disease.
    Grecuccio S; Sverzellati N; Uslenghi E; Caminati A; Pedrazzi G; Zompatori M
    Diagn Interv Radiol; 2021 May; 27(3):329-335. PubMed ID: 34003121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a CT-based deep learning algorithm to augment non-invasive diagnosis of idiopathic pulmonary fibrosis.
    Maddali MV; Kalra A; Muelly M; Reicher JJ
    Respir Med; 2023; 219():107428. PubMed ID: 37838076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning classifier is associated with mortality in interstitial lung disease: a retrospective validation study leveraging registry data.
    Selvan KC; Reicher J; Muelly M; Kalra A; Adegunsoye A
    BMC Pulm Med; 2024 May; 24(1):254. PubMed ID: 38783245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort study.
    Kampolis CF; Venetsanopoulou AI; Karakontaki F; Polychronopoulos V; Vlachoyiannopoulos P; Tzioufas AG
    Autoimmun Rev; 2018 Nov; 17(11):1124-1133. PubMed ID: 30213691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung Segmentation on HRCT and Volumetric CT for Diffuse Interstitial Lung Disease Using Deep Convolutional Neural Networks.
    Park B; Park H; Lee SM; Seo JB; Kim N
    J Digit Imaging; 2019 Dec; 32(6):1019-1026. PubMed ID: 31396776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases.
    Si-Mohamed SA; Nasser M; Colevray M; Nempont O; Lartaud PJ; Vlachomitrou A; Broussaud T; Ahmad K; Traclet J; Cottin V; Boussel L
    Eur Radiol; 2022 Jun; 32(6):4292-4303. PubMed ID: 35029730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study.
    Tanizawa K; Handa T; Kubo T; Chen-Yoshikawa TF; Aoyama A; Motoyama H; Hijiya K; Yoshizawa A; Oshima Y; Ikezoe K; Tokuda S; Nakatsuka Y; Murase Y; Nagai S; Muro S; Oga T; Chin K; Hirai T; Date H
    Respir Res; 2018 Aug; 19(1):162. PubMed ID: 30165854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.